+91 44 2496 8000 info@caplinpoint.net

CAPLIN POINT’S CRO AMARIS CLINICAL COMPLETES USFDA AUDIT WITH NIL OBSERVATIONS

Chennai, Sep 24, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Amaris Clinicals (Amaris), the Clinical Research Organization (CRO) division of Caplin Point Laboratories Limited, located at Chennai, has completed a virtual audit from United States Food and Drug Administration (USFDA) with NIL observations. Chairman C. C. Paarthipan commented “It is an excellent…

Read More »

CAPLIN STERILES GETS USFDA APPROVAL FOR LABETALOL HYDROCHLORIDE INJECTION USP

Chennai, September 08, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Labetalol Hydrochloride Injection USP, 100 mg/20 mL (5 mg/mL) and…

Read More »

CAPLIN STERILES RECEIVES APPROVAL FROM BRAZIL’S ANVISA

Chennai, August 17, 2021: Caplin Steriles Ltd, a subsidiary of Caplin Point Laboratories Ltd, has received approval from Brazil’s National Health Surveillance Agency ANVISA (Agência Nacional de Vigilância Sanitária) for its sterile injectable manufacturing site near Chennai, Tamilnadu. The approval grants access to the company to register and market its products in Brazil, the largest…

Read More »

CAPLIN STERILES GETS USFDA APPROVAL FOR SUMATRIPTAN INJECTION

Chennai, July 14, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Sumatriptan Injection USP, 6 mg/0.5 mL (12 mg/mL) Single…

Read More »

CAPLIN STERILES GETS USFDA APPROVAL FOR PROCHLORPERAZINE EDISYLATE INJECTION

Chennai, April 23, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Prochlorperazine Edisylate Injection USP, 10 mg/2 mL (5 mg/mL)…

Read More »

CAPLIN STERILES GETS USFDA APPROVAL FOR NEOSTIGMINE METHYLSULFATE INJECTION

Chennai, April 22, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Neostigmine Methylsulfate Injection USP, 5 mg/10 mL (0.5 mg/mL)…

Read More »

CAPLIN STERILES GETS USFDA APPROVAL FOR MILRINONE LACTATE INJECTION

Chennai, April 19, 2021: Caplin Point Laboratories Limited (BSE: CAPPL (524742), NSE: CAPLIPOINT) Caplin Steriles Limited (Caplin), a Subsidiary Company of Caplin Point Laboratories Limited, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Milrinone Lactate Injection USP, 10 mg/10 mL (1 mg/mL),…

Read More »

BT Business Leaders of TN: Manufacturing, electronics, SaaS can make India $5 trillion economy, say experts

Madan Krishnan, Vice President, and MD, Indian Subcontinent, India Medtronic, said human capital is the asset adding to it, adoption of technology in a better way to achieve a goal of $5 trillion economy. The thriving automotive industry, flourishing digital economy, and the vast scope in academics are some of the X-factors of Tamil Nadu…

Read More »